- Home
- CELU vs RBOT Comparison
CELU vs RBOT Comparison
Compare CELU & RBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELU
- RBOT
- Stock Information
- Founded
- CELU 2016
- RBOT 2014
- Country
- CELU United States
- RBOT United States
- Employees
- CELU N/A
- RBOT N/A
- Industry
- CELU Biotechnology: Pharmaceutical Preparations
- RBOT Medical Specialities
- Sector
- CELU Health Care
- RBOT Health Care
- Exchange
- CELU Nasdaq
- RBOT Nasdaq
- Market Cap
- CELU 42.2M
- RBOT 33.9M
- IPO Year
- CELU N/A
- RBOT N/A
- Fundamental
- Price
- CELU $1.61
- RBOT $8.50
- Analyst Decision
- CELU
- RBOT Hold
- Analyst Count
- CELU 0
- RBOT 2
- Target Price
- CELU N/A
- RBOT $9.25
- AVG Volume (30 Days)
- CELU 54.8K
- RBOT 19.6K
- Earning Date
- CELU 12-06-2024
- RBOT 05-02-2025
- Dividend Yield
- CELU N/A
- RBOT N/A
- EPS Growth
- CELU N/A
- RBOT N/A
- EPS
- CELU N/A
- RBOT N/A
- Revenue
- CELU $48,200,000.00
- RBOT N/A
- Revenue This Year
- CELU N/A
- RBOT N/A
- Revenue Next Year
- CELU $233.89
- RBOT N/A
- P/E Ratio
- CELU N/A
- RBOT N/A
- Revenue Growth
- CELU 225.94
- RBOT N/A
- 52 Week Low
- CELU $1.00
- RBOT $4.27
- 52 Week High
- CELU $5.22
- RBOT $19.00
- Technical
- Relative Strength Index (RSI)
- CELU 49.49
- RBOT 64.79
- Support Level
- CELU $1.47
- RBOT $5.21
- Resistance Level
- CELU $1.77
- RBOT $5.95
- Average True Range (ATR)
- CELU 0.16
- RBOT 0.65
- MACD
- CELU 0.01
- RBOT 0.43
- Stochastic Oscillator
- CELU 63.04
- RBOT 100.00
About CELU Celularity Inc.
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.
About RBOT Vicarious Surgical Inc.
Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port.